Compare RANI & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RANI | HOVR |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.9M | 116.3M |
| IPO Year | 2021 | 2022 |
| Metric | RANI | HOVR |
|---|---|---|
| Price | $0.86 | $1.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $7.50 | ★ $10.33 |
| AVG Volume (30 Days) | 1.0M | ★ 1.1M |
| Earning Date | 05-07-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,633,000.00 | N/A |
| Revenue This Year | $274.77 | N/A |
| Revenue Next Year | $79.44 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 58.85 | N/A |
| 52 Week Low | $0.44 | $1.16 |
| 52 Week High | $3.87 | $4.18 |
| Indicator | RANI | HOVR |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 46.02 |
| Support Level | $0.86 | $1.82 |
| Resistance Level | $0.95 | $1.91 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 65.07 | 26.67 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.